Hodder, S. L., Feinberg, J., Strathdee, S. A., Shoptaw, S., Altice, F., Ortenzio, L., & Beyrer, C. (2021). HIV and overdoses: diversifying therapies for opioid use disorder - Authors' reply. Lancet, 398(10302), 742. https://doi.org/10.1016/S0140-6736(21)01221-6

Hodder, Sally L., Judith Feinberg, Steffanie A. Strathdee, Steven Shoptaw, Frederick Altice, Louis Ortenzio, and Chris Beyrer. “HIV and overdoses: diversifying therapies for opioid use disorder - Authors' reply.” Lancet 398, no. 10302 (August 28, 2021): 742. https://doi.org/10.1016/S0140-6736(21)01221-6.

Hodder SL, Feinberg J, Strathdee SA, Shoptaw S, Altice F, Ortenzio L, et al. HIV and overdoses: diversifying therapies for opioid use disorder - Authors' reply. Lancet. 2021 Aug 28;398(10302):742.

Hodder, Sally L., et al. “HIV and overdoses: diversifying therapies for opioid use disorder - Authors' reply.” Lancet, vol. 398, no. 10302, Aug. 2021, p. 742. Pubmed, doi:10.1016/S0140-6736(21)01221-6.

Hodder SL, Feinberg J, Strathdee SA, Shoptaw S, Altice F, Ortenzio L, Beyrer C. HIV and overdoses: diversifying therapies for opioid use disorder - Authors' reply. Lancet. 2021 Aug 28;398(10302):742.